LATEST NEWS & EVENTS

• WAREHAM, MA, USA – April 14, 2009 - Synomics Pharmaceutical Services, LLC, a leader in preclinical and clinical bioanalytical services, storage stability, and analytical testing services for the pharmaceutical industry, announced that the Generic Pharmaceutical Association (GPhA®) has named Synomics Pharma as a contract research organization member. For the full story, Click here.
  
  
• PharmSep, LCGCs Symposium for Separation Scientists in Pharmaceuticals, to be held Sept 22-23 in Philadelphia , has invited Dr. Michael Swartz to speak about use of the Corona CAD detector in HPLC.
  
  
• Synomics Pharma’s Yu Zhou , Amber Awad , and Teresa Pekol and have been selected to present a poster at the 57th ASMS Conference, May 31 - June 4, 2009 in Philadelphia on "Comparison of SLE and SPE Sample Preparation for the Determination of Ibuprofen in Plasma."
  
  
• LCGC North America’s April Issue features an article titled Charged Aerosol Detection in Pharmaceutical Analysis: An Overview, written by a team of scientists at Synomics Pharma. Visit the Publications section of our Resources page for a link to the article.
  
  
• Synomics COO John Pirro participated in roundtable discussion, "The Challenges of Biopharmaceutical Manufacturing, in Next Generation Pharmaceutical."
  Read the article here
  
  
• Download the new Synomics Pharma Capabilities Brochure.
  Click here to download
  

Synomics Pharmaceutical Services, a leading global pharmaceutical Contract Research Organization (CRO), provides high-quality, client-specific drug testing solutions. We specialize in pre-clinical and clinical bioanalysis. We offer bioanalysis of controlled substances, as well as bioanalysis of sugars, lipids, proteins and peptides, and complex vitamins. Additionally, we have expertise in all ICH (long-term, short-term, and accelerated) stability studies for preclinical, clinical and commercial projects. Our strict adherence to client timelines and exceptional project management improves communication and reduces regulatory risk. By helping clients gain more control over their pharmaceutical life cycle process, we will assist you in meeting your aggressive deadlines.

Synomics Pharma brings you a broad portfolio of drug testing services in support of development through production. In response to manufacturers’ demands for a pharmaceutical Contract Research Organization that can adapt to changing requirements and regulations, Synomics Pharma has developed a quality management systems that allows us to address the complete product lifecycle.

As members of the GPHA, we provide unique services to support of manufacturers and distributors throughout the generic and pharmaceutical industry.